To treat means intervening once the pathology is already problematic.

There is one solution: prevention.

We are passionate about improving quality of life on a global scale. Our projects will help turn this passion into solid results.


The work of Prof. Damiano Turini and Prof. Giovanni Scapagnini have been particularly influential in our research dedicated to developing products that specifically target inflammations and infections

Safi Swiss Research is driven by a culture of innovation.
We utilize the decades of research on TRP channels by Prof. Turini to develop selective therapies for specific pathologies and optimize the absorption of molecules. Additionally, we take advantage of the non-pharmaceutical nature of our products to provide a lower risk profile and fewer contraindications for patients. We also innovate in our utilization of active ingredients to stay ahead of the competition.
The discovery of TRPs in Drosophila melanogaster led to the identification of the first mammalian TRP channels, which function as sensors for various stimuli. These channels have potential as therapeutic targets for physiological and pathological processes, and research has identified 28 different isoforms subdivided into six subfamilies. One of the most significant receptors is TRPV1, a vanilloid family member targeted with capsaicin to desensitize and block neurogenic inflammation, improving multiple disorders.

At Safi Swiss Research, we thrive in medical product testing through our advanced facilities, a team of expert researchers, and strict compliance with regulatory standards. With a diverse range of testing services tailored to each client’s needs, SAFI ensures the safety and effectiveness of all its products. Our efficient testing process expedites product development and regulatory approval, and we stand as a trusted leader in the industry, dedicated to upholding the highest testing standards.


We set the gold standard for quality control in the medical domain. With a relentless focus on compliance and precision, at Safi Swiss Research, we ensure that every single ingredient undergoes rigorous quality assessments. The quality control processes are meticulously designed to align with the most stringent regulatory requirements, abiding to ISO standards. The expert quality control team at Safi oversees every stage, from raw materials inspection to final product verification, assuring that all products meet or exceed industry compliance and safety benchmarks. In the realm of medical quality control, we stand as a beacon of reliability and unwavering commitment to upholding the highest standards of excellence.




At the core of our products is capsaicin, which serves as a critical exogenous agonist of TRP channels and a vital component of our formulations.


Green Tea Catechins

Molecular investigations have demonstrated that green tea catechins are effective in inhibiting the ability of the papillomavirus to produce proteins, thus effectively reducing its impact.



In vitro studies have shown that curcumin acts in a similar way, making it a promising ingredient for targeting HPV infections.


Our research is constantly evolving, and we strive to apply active ingredients in innovative and synergistic ways to enhance the quality of life for our patients. Our mission is to become a leading provider of pharmaceuticals and parapharmaceuticals with innovative formulations, rooted in research and the pursuit of wellness. We are deeply committed to meeting the evolving needs of the modern concept of well-being and working in close collaboration with medical professionals to anticipate and respond to the needs of patients.


* By signing up, you consent to receive Safi Swiss Research newsletters.

Safi Swiss Research
Innovation drives Safi Swiss Research. Pharmaceuticals and parapharmaceuticals based on innovative formulations, focussing on research and the pursuit of wellness.

© Safi Swiss Research. All rights reserved. P.IVA 02885321204